Get access to our best features
Get access to our best features
Published

This UK stock looks pretty cheap to me

Summary by The Motley Fool UK
I’m always scanning the UK stock market for value, and occasionally find that the largest companies in the market are trading for far less than expected. I recently took a closer look at pharmaceutical giant AstraZeneca (LSE: AZN), a FTSE 100 heavyweight. In a tough period The shares are experiencing the most significant weekly decline since July 2023. This is primarily due to disappointing results from a late-stage trial of an experimental lu…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)